PRELUDE THERAPEUTICS INC Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
PRELUDE THERAPEUTICS INC (PRLD) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $29.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-10
- PRELUDE THERAPEUTICS INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $29.30M, a 16.29% decline from fiscal 2024.
- PRELUDE THERAPEUTICS INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $35.00M, a 4.37% decline from fiscal 2023.
- PRELUDE THERAPEUTICS INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $36.60M, a 2.52% increase from fiscal 2022.
- PRELUDE THERAPEUTICS INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $35.70M, a 16.00% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $29.30M 10-K · filed 2026-03-10 |
| 2024-12-31 | $35.00M 10-K · filed 2026-03-10 |
| 2023-12-31 | $36.60M 10-K · filed 2025-03-10 |
| 2022-12-31 | $35.70M 10-K · filed 2024-02-15 |
| 2021-12-31 | $42.50M 10-K · filed 2023-03-15 |
| 2020-12-31 | $17.50M 10-K · filed 2022-03-17 |
| 2019-12-31 | $9.20M 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |